A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes
Clinical trial NCT03298542 · COMPLETED
Trial details
- NCT number
- NCT03298542
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2020-12-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.